Tokyo Tape
Sign in
← Chordia Therapeutics

Quarterly report · Q3

190A.TEDINET S100U27N
Period2023-09-01 → 2024-05-31
Filed2024-07-16
StandardJapan GAAP
ConsolidatedNo
Data checks8 of 8 passed
Key figures · 21
MetricValuePeriodScopeSource row
Operating income−¥1.2bn2023-09-01 → 2024-05-31StandaloneOperating income
Ordinary income−¥1.2bn2023-09-01 → 2024-05-31StandaloneOrdinary income
Ordinary income¥226m2022-09-01 → 2023-08-31StandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-09-01 → 2024-05-31StandaloneIncome before income taxes
Net income−¥1.2bn2023-09-01 → 2024-05-31StandaloneProfit loss
Net income¥223m2022-09-01 → 2023-08-31StandaloneNet income loss (5-year summary)
Total assets¥3.5bnat 2024-05-31StandaloneAssets
Total assets¥4.9bnat 2023-08-31StandaloneAssets
Total liabilities¥139mat 2024-05-31StandaloneLiabilities
Total liabilities¥408mat 2023-08-31StandaloneLiabilities
Net assets / equity¥3.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥4.5bnat 2023-08-31StandaloneNet assets
Cash and deposits¥3.3bnat 2024-05-31StandaloneCash and deposits
Cash and deposits¥4.8bnat 2023-08-31StandaloneCash and deposits
EPS (basic)¥-20.862023-09-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.642024-03-01 → 2024-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥3.962022-09-01 → 2023-08-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio95.2%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.2%at 2023-08-31StandaloneEquity to asset ratio (5-year summary)
Shares issued56,443,800at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued56,443,800at 2023-08-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 198
ItemContextValueUnit
Net assetsPrior1YearInstant_NonConsolidatedMember4500881000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember3323402000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4909123000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember3462039000JPY
Business revenue rev oaCurrentYTDDuration_NonConsolidatedMember－JPY
Research and development expense cos exp oaCurrentYTDDuration_NonConsolidatedMember984457000JPY
Selling general and administrative expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember196366000JPY
Business expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember1180823000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-1180823000JPY
Subsidy income noi bountyCurrentYTDDuration_NonConsolidatedMember17727000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember102000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember17829000JPY
Listing expenses noeCurrentYTDDuration_NonConsolidatedMember6110000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember6560000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember12671000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-1175664000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-1175664000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1815000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1815000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-1177479000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-07-16
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第７期第３四半期（自2024年３月１日　至2024年５月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社
Company name in english cover pageFilingDateInstantＣｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　三宅　洋
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の１
Telephone number address of registered headquarter cover pageFilingDateInstant03-6661-9543
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)財務部長　久米　健太郎
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の１
Telephone number nearest place of contact cover pageFilingDateInstant03-6661-9543
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)財務部長　久米　健太郎
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38905
Fund codeFilingDateInstant－
Security codeFilingDateInstant190A0
Filer name in japaneseFilingDateInstant
Original text (Japanese)Chordia Therapeutics株式会社
Filer name in englishFilingDateInstantChordia Therapeutics Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2023-09-01
Current period end dateFilingDateInstant2024-05-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 8 of 8 passed
balance sheet identitynon_consolidated 2023-08-31pass rounding
balance sheet identitynon_consolidated 2024-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-08-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · total assetsnon_consolidated 2023-08-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass